srch

11.03.2021 · ACS Medicinal Chemistry Letters 2021, 12, 3, 494-501 (Letter) Publication Date (Web): March 2, 2021. Abstract. Full text. PDF. ABSTRACT. Indoleamine 2,3-dioxygenase 1 (IDO1) has been identified as a target for small-molecule immunotherapy for the treatment of a variety of cancers including renal cell carcinoma and metastatic melanoma.

ACS Medicinal Chemistry Letters: Technology Notes ACS Med Chem Lett. 2017 Jan 12;8(1):1-2. doi: 10.1021/acsmedchemlett.6b00484. Author Peter Wipf 1 ...

14.10.2021 · STEP 1: Login with ACS ID Logged in Success. Click to create an ACS ID. STEP 2: Login with Mendeley Logged in Success. Create a Mendeley account. Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

New Drug Modalities in Medicinal Chemistry, Pharmacology, and Translational Science. ACS Medicinal Chemistry Letters, ACS Pharmacology & Translational Science, and Journal of Medicinal Chemistry welcome submissions to this joint Virtual Special Issue. Submission deadline: July 31, 2022. Read the Editorial to learn more

ACS Medicinal Chemistry Letters , ACS Pharmacology & Translational Science , and Journal of Medicinal Chemistry welcome submissions to this joint Virtual ...

ACS Med Chem Lett Articles from this journal are generally available in PMC after a 12-month delay (embargo); however, the delay may vary at the discretion of the publisher. ACS Medicinal Chemistry Letters

ACS Medicinal Chemistry Letters, Articles ASAP (Patent Highlight) Publication Date (Web): January 12, 2022. Full text; PDF; January 11, 2022. Indole-Containing Pyrazino[2,1-b]quinazoline-3,6-diones Active against Plasmodium and Trypanosomatids. Solida …

Citation Style: Superscripted Number. Date: Tuesday, October 26, 2021. Discipline: Chemistry. File Name: ACS Med Chem Lett.ens. Publisher: American Chemical ...

ACS Medicinal Chemistry Letters ; 2020/2021, -, 4.345 ; 2019, -, 3.975 ; 2018, -, 3.737 ; 2017, -, 3.794 ...

New Drug Modalities in Medicinal Chemistry, Pharmacology, and Translational Science. ACS Medicinal Chemistry Letters , ACS Pharmacology & Translational ...

Oct 14, 2021 · STEP 1: Login with ACS ID Logged in Success. Click to create an ACS ID. STEP 2: Login with Mendeley Logged in Success. Create a Mendeley account. Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

Jul 10, 2014 · - Journal of Combinatorial Chemistry; ACS Earth and Space Chemistry; ACS Energy Letters; ACS Infectious Diseases; ACS Macro Letters; ACS Materials Letters - New in 2019; ACS Medicinal Chemistry Letters; ACS Nano; ACS Omega; ACS Pharmacology & Translational Science; ACS Photonics; ACS Sensors; ACS Sustainable Chemistry & Engineering; ACS ...

Discovery of Spirocyclic Androgen Receptor Protein Degraders for the Treatment of Prostate Cancer. Robert B. Kargbo*. ACS Medicinal Chemistry Letters 2021, 12, 11, 1635-1636 (Patent Highlight) Publication Date (Web): October 7, 2021. Full text.

01.02.2022 · The Journal of Medicinal Chemistry (JMC), ACS Medicinal Chemistry Letters (ACS MCL), and the ACS Division of Medicinal Chemistry (MEDI) are thrilled to announce a call for nominations for the Philip S. Portoghese Journal of Medicinal Chemistry/ACS Medicinal Chemistry Letters/Division of Medicinal Chemistry Joint Lectureship Awards.In 2022, ACS …

ACS Medicinal Chemistry Letters, ACS Pharmacology & Translational Science, and Journal of Medicinal Chemistry welcome submissions to this joint Virtual Special Issue. Submission deadline: July 31, 2022. Read the Editorial to learn more. Epigenetics: Targeting Chromatin- and RNA- Modifications.

The Psychedelic Renaissance: Addressing Potential Adverse Effects in a Therapeutic Setting. Robert B. Kargbo*. ACS Medicinal Chemistry Letters 2021, 12, 12, 1874-1875 (Patent Highlight) Publication Date (Web): November 8, 2021. Full text.

ACS Medicinal Chemistry Letters is interested in receiving manuscripts that discuss various aspects of medicinal chemistry. The journal will publish studies ...

ACS Medicinal Chemistry Letters is interested in receiving manuscripts that discuss various aspects of medicinal chemistry. The journal will publish studies that pertain to a broad range of subject matter, including compound design and optimization, biological evaluation, drug delivery, imaging agents, and pharmacology of both small and large bioactive molecules. Specific areas include but are ...

ACS Med Chem Lett Articles from this journal are generally available in PMC after a 12-month delay (embargo); however, the delay may vary at the discretion of the publisher. ACS Medicinal Chemistry Letters

Journal List; ACS Med Chem Lett. Logo of acsmedlett. ACS Med Chem Lett. Articles from this journal are generally available in PMC after a 12-month delay ...

ACS Medicinal Chemistry Letters Latest Impact Factor IF 2021-2022 is 4.345. More IF Trend, Prediction, Ranking & Analysis.

ACS Medicinal Chemistry Letters is a monthly peer-reviewed scientific journal covering medicinal chemistry. It was established in 2009 and is published by ...